A mass spec-based method for analyzing the structure of lipid nanoparticles could yield new insights that improve vaccine and ...

Alongside its expansion into low-scale oligo synthesis, the company has rebranded its custom oligos to better target ...

Researchers have developed a new suite of genetic tools for cell-type specific targeting to battle brain disease.

This week a group of researchers, bioethicists, publishers and theologians are discussing the merits of human heritable genome editing.

A precipitation-based chromatography alternative, a novel viral vector isolation tech, and a glycosylation prediction system are among the projects awarded funding in the latest round of grants issued ...

Kaida BioPharma is advancing targeted anti-cancer hormonal therapies to address the root cause of cancers affecting women.

These microbes produce metabolites that might be used to treat bacterial infections, cancer, type 2 diabetes, and much more.

With several surfactants to choose from, the biopharma industry is still working to identify the most effective, environmentally friendly alternatives to the surfactant Triton X-100 (TX-100). The EU ...

Genmab says choosing to insource cell-line development helped them to improve the antibody titers they were achieving.

CRISPR-edited iPSCs uncover early mitochondrial defects shared across ALS mutations, revealing pathways that could guide future treatments.